Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SPRO

+ Watchlist+ Portfolio

Spero Therapeutics, Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.90
52-Week Range
$0.87 – $3.08
Market Cap
$50.92M
P/E (TTM)
—
EPS (TTM)
-0.49
Dividend Yield
0.00%
Advanced Metrics
Price/Book
67.23
PEG Ratio
—
Return on Equity
-216.41%
Return on Assets
5.35%
Gross Margin
7.43%
Operating Margin
16.91%
Profit Margin
-71.02%
Current Ratio
—
Debt/Equity
—
Total Debt
$0.00
Free Cash Flow
—
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$-57.04M

Market Snapshot

About

Spero Therapeutics is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing treatments for multi-drug resistant bacterial infections. The company is developing novel therapies designed to address the growing global threat of antibiotic resistance.